AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Hot Flashes - API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

The ′ Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018′ report provides comprehensive insights about marketed and Phase III products for Hot Flashes. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Hot Flashes

Coverage of API manufacturers for Hot Flashes marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Hot Flashes

This report provides a comprehensive understanding of the emerging Phase III therapies for Hot Flashes which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Hot Flashes: Overview

Risk Factors Causes Symptoms Pathophysiology Prognosis Diagnosis Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

Product Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Clinical Trials Regulatory Milestones Product Development Activities United States Europe Historical Global Sales Forecasted Global Sales

5. Emerging Therapies (Phase III)

Product Description Research and Development Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/n8tzqc/global_hot?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005337/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Sexual and Reproductive Health Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 06:59 AM/DISC: 12/19/2018 06:59 AM

http://www.businesswire.com/news/home/20181219005337/en